Business
SERA PROGNOSTICS APPOINTS LEE ANDERSON AS CHIEF COMMERCIAL OFFICER
Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today announced the appointment of Lee Anderson as Chief Commercial Officer. Bringing more than 30 years of cross-functional leadership experience in sales, marketing, customer service, strategic accounts, and training, Mr. Anderson has a proven track record of driving business growth and enhancing sales s
About this update from Sera Prognostics, Inc.
[{"type":"text","content":"Industry Veteran to Spearhead Commercial Expansion, Driving Innovation and Growth at the Company","length":96,"tagName":"p","attribs":{}},{"type":"text","content":"SALT LAKE CITY, May 8, 2025 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today announced the appointment of Lee Anderson as Chief Commercial Officer. Bringing more than 30 years of cross-functional leadership experience in sales, marketing, customer service, strategic accounts, and training, Mr. Anderson has a proven track record of driving business growth and enhancing sales strategies in the healthcare sector.","length":584,"tagName":"p"},{"type":"image","alt":"Lee Anderson","displaySize":"","headline":null,"caption":"Lee Anderson","className":"","disableSlideshowImg":false,"size":{"original":{"width":276,"height":400,"url":"https://media.zenfs.com/en/prnewswire.com/03288ee08d9a69ec2c24094fb1e29866"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/uK9CQXRhsGprxe.K_KaggA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTYwOTtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/03288ee08d9a69ec2c24094fb1e29866","width":276,"height":400}},"href":"https://mma.prnewswire.com/media/2682907/Lee_Anderson.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":""Lee is a highly accomplished leader with commercial expertise in fostering innovation, supporting continuous optimization and driving sales and offers a history of strong performance within the healthcare and diagnostics space," said Zhenya Lindgardt, President and CEO of Sera Prognostics. "With Sera now in the commercial phase following the strong results of our pivotal PRIME study, Lee will play a critical role in expanding adoption and sales of our PreTRM Test and we enthusiastically welcome Lee to our leadership team."","length":549,"tagName":"p"},{"type":"text","content":"Mr. Anderson comes to Sera with a robust track record in leadership roles within the biotechnology and diagnostics sector, primarily highlighted by his transformative tenure at Genomic Health and Exact Sciences. At Genomic Health, which was later acquired by Exact Sciences, he escalated through various levels of increasing responsibility, finally spearheadi...